# A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

> **NCT01285752** · PHASE2 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 240 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AK106-001616
- **DRUG:** AK106-001616
- **DRUG:** Active comparator

## Key facts

- **NCT ID:** NCT01285752
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285752, "A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01285752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*